Age-Related Differences in Plasma Proteins: How Plasma Proteins Change from Neonates to Adults
Open Access
- 18 February 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (2), e17213
- https://doi.org/10.1371/journal.pone.0017213
Abstract
The incidence of major diseases such as cardiovascular disease, thrombosis and cancer increases with age and is the major cause of mortality world-wide, with neonates and children somehow protected from such diseases of ageing. We hypothesized that there are major developmental differences in plasma proteins and that these contribute to age-related changes in the incidence of major diseases. We evaluated the human plasma proteome in healthy neonates, children and adults using the 2D-DIGE approach. We demonstrate significant changes in number and abundance of up to 100 protein spots that have marked differences in during the transition of the plasma proteome from neonate and child through to adult. These proteins are known to be involved in numerous physiological processes such as iron transport and homeostasis, immune response, haemostasis and apoptosis, amongst others. Importantly, we determined that the proteins that are differentially expressed with age are not the same proteins that are differentially expressed with gender and that the degree of phosphorylation of plasma proteins also changes with age. Given the multi-functionality of these proteins in human physiology, understanding the differences in the plasma proteome in neonates and children compared to adults will make a major contribution to our understanding of developmental biology in humans.This publication has 32 references indexed in Scilit:
- Age‐specific differences in binding of heparin to plasma proteinsJournal of Thrombosis and Haemostasis, 2010
- Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarkerBMC Cancer, 2010
- Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics ProgramsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- High Dynamic Range Characterization of the Trauma Patient Plasma ProteomeMolecular & Cellular Proteomics, 2006
- Classification and Characterization of Hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (Unclassifiable) von Willebrand DiseaseClinical and Applied Thrombosis/hemostasis, 2006
- Proteomics-Based Strategy to Identify Biomarkers and Pharmacological Targets in Leukemias with t(4;11) TranslocationsJournal of Proteome Research, 2006
- Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: Search for novel biomarkers of cystic fibrosis lung diseaseProteomics, 2006
- Developmental haemostasisThrombosis and Haemostasis, 2006
- Human α2-macroglobulin: genotype–phenotype relationExperimental Neurology, 2003